Is AI taking over the world? Some pretty smart people seem to think so. Richard explains why AI for genomics is in a position to help save human lives!
Frances’ explains the term ‘designer baby’, and shares a personal story about why she’s never considered herself neither a designer baby nor a saviour child
Guest blogger Mack Veltman asks, at what point does natural life become a scientific plaything for humans to change at their leisure?
MassGenomics’ Dan Koboldt breaks the research down into the statistics of expression quantitative trait loci and just what they mean for gene expression
Dr Strange hit the big screen promising a lot, and FLG manging editor Carl Smith went to find out if the movie delivers
We round up the international media responses to the National Academy of Sciences consensus report on human genome editing
Trying to stay politically neutral is getting tougher and tougher at FLG, but everyone now and again we need to get serious. This time, it’s immigration.
Move over post-truth, welcome to the era of ‘alternative facts’. We decided to take an alternate look at some of the facts surrounding gene editing
Open any news source right now and you’ll find a story about “three parent babies”. Here’s our handy guide to all things mitochondrial donation
Happy Friday 13th! Hopefully you are not a sufferer of friggatriskaidekaphobia, a phobia of this rare and unusual day
Which scientists, living, dead, or fictional, would you invite to a dinner party and why? The guest list for the ultimate genomics party looks pretty good!
A festive roundup to cheer you through the final panic purchasing before the holiday season gets underway. Happy holidays!
We want to spread the goodwill, and see how well you’ve been keeping up with the world of genomics, in our first ever FLG Quiz of 2016!
The email BCC can be a tricky beast to work with. As Theranos found out this week, a conversation can seem so secure, until it isn’t
Guest editors Elaine Mardis and Marc Ladanyi involved in special issue of PLOS Medicine with a clinical cancer genomics focus